Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.91% Nasdaq Up0.87%

Galectin Therapeutics, Inc. (GALT)

-NasdaqCM

3.98 Down 0.18(4.33%) 3:59PM EDT

Add to Portfolio
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.0
Mean Recommendation (last week):2.0
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)Compare to Industry

Price Target Summary
Mean Target:7.00
Median Target:7.00
High Target:7.00
Low Target:7.00
No. of Brokers:1

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Oct 17, 2000Banc of America SecDowngradeBuyMarket Perform
Jul 18, 2000Bear StearnsUpgradeNeutralAttractive
May 29, 2000Salomon Smth BrnyUpgradeOutperformBuy
Apr 10, 2000Adams HarknessDowngradeStrong BuyAccumulate
Feb 29, 2000Bear StearnsDowngradeAttractiveNeutral
Feb 29, 2000SG CowenDowngradeBuyNeutral
Feb 29, 2000Deutsche Bc Alex. BrDowngradeStrong BuyMkt Perform
Jan 18, 2000Banc of America SecDowngradeStrong BuyBuy
Jan 18, 2000Needham & CoDowngradeStrong BuyBuy
Jan 18, 2000Robertson StephensDowngradeBuyLT Attractive

More Upgrades & Downgrades for GALT

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0000
Buy0000
Hold0000
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.